Analysis of 500 liver transplantations in the Bellvitge Hospital, Spain;Análisis de 500 trasplantes hepáticos en el Hospital de Bellvitge

Medicina Clinica

Volumn 115, Issue 14, 2000, Pages 521-629

  Jaurrieta, Eduardo ^a   Casais, Luis ^a   Figueras, Juan ^a   Ramos, Emilio ^a   Lama, Carmen ^a   Rafecas, Antonio ^a   Taltavull, Teresa Casanovas ^a   Fabregat, Juan ^a   Xiol, Xavier ^a   Torras, Jaume ^a   Baliellas, Carmen ^a   Sabaté, Antonio ^a   Rufí, Gabriel ^a   Benasco, Carmen ^a   Casanovas, Teodoro ^a   Serrano, Teresa ^a   Gil Vernet, Salvador ^a   Sabaté, Isabel ^a   Busquets, Juli ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Liver transplantation; Postoperative complications; Results; Survival

Indexed keywords

AGE; ARTICLE; BILE DUCT FISTULA; BLOOD COMPONENT THERAPY; CAUSE OF DEATH; DONOR; FEMALE; GRAFT REJECTION; HEALTH CARE QUALITY; HEPATITIS C; HUMAN; INFECTION; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; REOPERATION; SPAIN; STATISTICS; THROMBOSIS; UTILIZATION REVIEW;

AGE FACTORS; BILIARY FISTULA; BLOOD COMPONENT TRANSFUSION; CAUSE OF DEATH; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMANS; INFECTION; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGRAM EVALUATION; REOPERATION; SPAIN; THROMBOSIS; TISSUE DONORS;

EID: 0034727377     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71614-9     Document Type: Article

References (44)

1. Starzl TE, Marchioro TL, Von Kaula KN, Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-662.
2. Starlz TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli B, Malatack JJ et al. Evolution of liver transplantation. Hepatology 1982; 2: 614-636.
3. UNOS Richmon, Va Division of organ transplantation bureau of health resourcees development, health resources and services administration. Annual report of scientific registry of transplant recipients and the organ procurement and transplantation Network. Tranasplant Data 1988-1983, Bethesda, Md: VS Dept. of Health and Human Servies, 1994.
4. Starzl TE, Iwatsuki S, Shaw BW Jr. Technique of liver transplantation. En: Blumgart LH, editor. Surgery of the liver and biliary tract. Edimburgo: Churchill Livingstone, 1985.
5. Griffith BP, Shaw BW Jr, Hardesty RL. Veno-venous bypass without systemic anticoagulation for tansplantation of the human liver. Surg Gynecol Obstet 1985; 160. 270-272.
6. Figueras J,Sabaté A, Fabregat J, Torras J, Drudis R, Rafecas A et al. Hemodynamics during the anhepatic phase in orthotopic liver transplantation with vena cava preservation: a comparative study. Transplant Proc 1993; 25: 1588-1589.
7. Calne RY, Williams R. Liver transplantation in man. In Observations on technique and organization in five cases. Br Med J 1968; 4: 535-540.
8. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of inferior vena cava. Ann Surg 1989; 210: 649-652.
9. Parrilla P, Sánchez-Bueno F, Figueras J, Jaurrieta E, Mir J, Margarit C et al. Analysis of the complications of the piggy-back technique in 1112 liver transplants. Transplantation 1999; 67 1214-1217.
10. Fabregat J, Fradera R, Figueras J, Rafecas A, Torras J, Martínez LaCasa J et al. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection. Transplant Proc 1994; 26: 2697-2699.
11. Torras J, Figueras J, Lama C, Fabregat J, Ramos E, Rafecas A et al. Mycophenolate mofetil overlap in liver transplant recipient with chronic cyclosporine nephrotoxicity. Transplant Proc 1999; 31: 2430.
12. Strasberg SM, Howard TK, McImenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after live transplantation. Hepatology 1994; 20: 829-838.
13. Jiménez C, Moreno González E, Colina F, Palma F, Loinaz C, Rodríguez F et al. Use of octogenarian livers safety expands the donor pool. Transplantation 1999; 68: 572-575.
14. Grande L, Malus D, Rimola A, Manyalic M, Cabrer C, Garcia-Valdecasas JC et al. Expanded liver door age over 60 years for hepatic transplantation J Clin Transpl 1998; 297-301.
15. Busquest J, Figueras J, Torras J, Fabregat J, Rafecas A, Ramos E et al. Liver donors: is age a risk factor? Transplant Proc 1999; 31: 2480-2481.
16. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27: 1572-1577.
17. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A et al. Resection of transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 580-587.
18. Valls C, Figueras J, Jaurrieta E, Sancho C, Dominguez J, Benasco C et al. Hepatocellular carcinoma: iodized-oil CT TNM classification. Am J Roentgenol 1996; 167: 477-481.
19. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485-1489.
20. Figueras J, Ramos E, Ibánez L, Rafecas A, Fabregat J, Torras J et al. Comparative study of survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma. Transplant Proc 1999; 31: 2487-2488.
21. Figueras J, Torras J, Rafecas A, Fabregat J, Ramos E, Moreno G et al. Extra-anatoic venous graft for portal vein thrombosis in liver transplantation. Transpl Int 1997; 10: 407-408.
22. Figueras J, Busquets J, Dominguez J, Sancho C, Casanovas-Taltavull T, Rafecas A et al. Intra-arterial thrombolysis in the treatment of acute hepatic artery thrombosis after liver transplantation. Transplantation 1995; 59: 1356-1357.
23. Torras J, Lladó L, Figueras J, Ramos E, Lama C, Fabregat J et al. Diagnostic and therapeutic managment of hepatic artery thrombosis after liver transplantation. Transplant Proc, 1999; 31: 2405.
24. Figueras J, Pared D, Aranda H, Rafecas A, Fabregat J, Torras J et al. Results of using the recipient's splenic artery for arterial reconstruction in liver transplantation in 23 patients Transplantation 1997; 64: 655-658.
25. Figueras J, Torras J, Aranda H, Rafecas A, Fabregat J, Ramos E. Revascularization of liver grafts with recipient splenic artery in liver transplantation. Transplant Proc 1995; 27: 2313-2314.
26. Abbasoglu O, Levy MF, Testa G, Obiekwe S, Brick BS, Jennings LW et al. Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation 1998; 66: 598-601.
27. Torras J, Lladó L, Figueras J, Ramos E, Lama C, Fabregat J et al. Biliary tract complication after liver transplantation: type, management, and outcome. Transplant Proc 1999; 31: 2406.
28. Sankary HN, McCnesney L, Frye E, Cohn S, Foster P, Williams J. A simple modification in operative technique can reduce the incidence of nonanastomotic biliary structures after orthtopic liver transplantation. Hepatology 1995; 21: 63-69.
29. García-Huete L, Doménech P Sabaté A, Martínez-Brotons F, Jaurrieta E, Figueras J. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology 1997; 26: 1143-1148.
30. Dalmau A, Sabaté A, Acosta F, Garcia-Huete L, Koo M, Reche M et al. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation Transplant Proc 1999; 6: 2361-2362.
31. Roche E, Antonio P, Ramo J, Hermida J. Aprotinina en el control de Ia hemorragia quirúrgica. Med Clin (Barc) 1996; 106: 307-316.
32. Llamas P, Cabrera R, Gómez-Arnau J, Fernández MN, Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin. Haematologica 1998; 83: 338-346.
33. Miguélez M, Lumbreras C, Herrero JA, Agudo JM, Del Palacio A et al. Infección fúngica profunda en receptcres de un trasplante hepático: análisis de 21 casos. Med Clin (Barc) 1998; 110: 406-410.
34. Lumbreras C, Otero JR, Aguado JM. Lizasoain M, Gómez R, Garcia I et al. Estudio prospectivo de la infección por citomegalovirus en receptores de trasplante hepático. Med Clin (Barc) 1992; 99: 401-405.
35. Niubó J, Viqueira M, García A, Manito N, Pérez JL, Martín R, La muestra de sangre como marcador viral de infección por citomegalovirus en pacientes con trasplante hepático y cardíaco. Med Clin (Barc) 1996; 107: 246-249.
36. Fabregat J, Fradera R, Jaurrieta E, Figueras J, Rafecas A, Rufi G et al. Clinical results of quadruple drug immunosuppression in liver transplantation. Transplant Proc 1992; 24: 148-149.
37. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clement G et al. Liver transplantation in hepatitis C. A Spanish multi-centre epxerience. Eur J Gastroenterol Hepatol 1998; 10: 771-776.
38. Casafont F, Carte B, Lozano JL, Fábrega E, Sánchez-Antolin G, Dueñas C et al. Recidiva de hepatitis por el virus de la hepatitis C en ios pacientes receptores de trasplante hepàtico. Med Clin (Barc) 1997; 108: 98-102.
39. Singh N, Gayowski T, Wagener MM, Marino IR. Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation 1999; 67: 69-72.
40. Galve ML, Cuervas-Mons V, Figueras J, Herrero I, Mata M, Clement G et al. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc 1999; 31: 1275-1277.
41. Berenguer M, Prieto M, Bustamante M, Carrasco D, López-Andújar R, Mir J et al. Incidencia de las neoplasias de novo después del trasplante hepático. Med Clin (Barc) 1998; 111: 481-484.
42. Ribas Y, Rafecas A, Figueras J, Benasco C, Fabregat J, Torras J et al. Post-transplant lymphoma in a liver allograft. Transpl Int 1995; 6: 488-491.
43. Parés D, Figueras J, Rafecas A, Fabregal J, Torras J, Ramos E et al. Influence of renal function upon the outcome of liver retransplanted patients: results of a multivariate analysis. Transplant Proc 1999; 31: 2485-2486.
44. Pares D, Figueras J, Rafecas A, Fabregat J, Torras J, Ramos E et al. Retrasplante hepático en adultos: evolución y resultados Gastroenterol Hepatol 1999; 22: 1-6.